BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36291095)

  • 1. Autoantibody against Tumor-Associated Antigens as Diagnostic Biomarkers in Hispanic Patients with Hepatocellular Carcinoma.
    Ma Y; Qiu C; Wang B; Zhang X; Wang X; Aguilera RJ; Zhang JY
    Cells; 2022 Oct; 11(20):. PubMed ID: 36291095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using immunomic approach to enhance tumor-associated autoantibody detection in diagnosis of hepatocellular carcinoma.
    Dai L; Ren P; Liu M; Imai H; Tan EM; Zhang JY
    Clin Immunol; 2014; 152(1-2):127-39. PubMed ID: 24667685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies to PAX5, PTCH1, and GNA11 as Serological Biomarkers in the Detection of Hepatocellular Carcinoma in Hispanic Americans.
    Qiu C; Ma Y; Wang B; Zhang X; Wang X; Zhang JY
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel immunodiagnosis panel for hepatocellular carcinoma based on bioinformatics and the autoantibody-antigen system.
    Wu J; Wang P; Han Z; Li T; Yi C; Qiu C; Yang Q; Sun G; Dai L; Shi J; Wang K; Ye H
    Cancer Sci; 2022 Feb; 113(2):411-422. PubMed ID: 34821436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early detection of hepatocellular carcinoma using autoantibody profiles from a panel of tumor-associated antigens.
    Koziol JA; Imai H; Dai L; Zhang JY; Tan EM
    Cancer Immunol Immunother; 2018 May; 67(5):835-841. PubMed ID: 29497780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody detection using tumor-associated antigen mini-array in immunodiagnosing human hepatocellular carcinoma.
    Zhang JY; Megliorino R; Peng XX; Tan EM; Chen Y; Chan EK
    J Hepatol; 2007 Jan; 46(1):107-14. PubMed ID: 17067715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Six autoantibodies as potential serum biomarkers of hepatocellular carcinoma: A prospective multicenter study.
    Okada R; Otsuka Y; Wakabayashi T; Shinoda M; Aoki T; Murakami M; Arizumi S; Yamamoto M; Aramaki O; Takayama T; Wakiyama S; Yanaga K; Amikura K; Kaneko H; Shimada H
    Int J Cancer; 2020 Nov; 147(9):2578-2586. PubMed ID: 32574375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of anti-SF3B1 autoantibody as a diagnostic marker in patients with hepatocellular carcinoma.
    Hwang HM; Heo CK; Lee HJ; Kwak SS; Lim WH; Yoo JS; Yu DY; Lim KJ; Kim JY; Cho EW
    J Transl Med; 2018 Jun; 16(1):177. PubMed ID: 29954402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies against glucose-regulated protein 78 as serological biomarkers in metastatic and recurrent hepatocellular carcinoma.
    Ying X; Han SX; He CC; Zhou CY; Dong YP; Cai MJ; Sui X; Ma CX; Sun X; Zhang YY; Gou WL; Mason C; Zhu Q
    Oncotarget; 2017 Apr; 8(15):24828-24839. PubMed ID: 28186997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using Serological Proteome Analysis to Identify Serum Anti-Nucleophosmin 1 Autoantibody as a Potential Biomarker in European-American and African-American Patients With Prostate Cancer.
    Dai L; Li J; Xing M; Sanchez TW; Casiano CA; Zhang JY
    Prostate; 2016 Nov; 76(15):1375-86. PubMed ID: 27418398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibody signature in hepatocellular carcinoma using seromics.
    Zhang S; Liu Y; Chen J; Shu H; Shen S; Li Y; Lu X; Cao X; Dong L; Shi J; Cao Y; Wang X; Zhou J; Liu Y; Chen L; Fan J; Ding G; Gao Q
    J Hematol Oncol; 2020 Jul; 13(1):85. PubMed ID: 32616055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer.
    Dai L; Qu Y; Li J; Wang X; Wang K; Wang P; Jiang BH; Zhang J
    Oncotarget; 2017 May; 8(22):36664-36673. PubMed ID: 28456790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies to tumor-associated antigens as diagnostic biomarkers in hepatocellular carcinoma and other solid tumors.
    Zhang JY; Tan EM
    Expert Rev Mol Diagn; 2010 Apr; 10(3):321-8. PubMed ID: 20370589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Proteome Microarray identifies autoantibodies to tumor-associated antigens as serological biomarkers for the diagnosis of hepatocellular carcinoma.
    Yang Q; Ye H; Sun G; Wang K; Dai L; Qiu C; Shi J; Zhu J; Wang X; Wang P
    Mol Oncol; 2023 May; 17(5):887-900. PubMed ID: 36587394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibody detection to tumor-associated antigens of P53, IMP1, P16, cyclin B1, P62, C-myc, Survivn, and Koc for the screening of high-risk subjects and early detection of esophageal squamous cell carcinoma.
    Zhou SL; Yue WB; Fan ZM; Du F; Liu BC; Li B; Han XN; Ku JW; Zhao XK; Zhang P; Cui J; Zhou FY; Zhang LQ; Fan XP; Zhou YF; Zhu LL; Liu HY; Wang LD
    Dis Esophagus; 2014; 27(8):790-7. PubMed ID: 24147952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using a panel of multiple tumor-associated antigens to enhance the autoantibody detection in the immunodiagnosis of ovarian cancer.
    Wang P; Qin J; Ye H; Li L; Wang X; Zhang J
    J Cell Biochem; 2019 Mar; 120(3):3091-3100. PubMed ID: 30484895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Analysis of Immunoreactive Signatures in Early Stage Hepatocellular Carcinoma.
    Hong Y; Long J; Li H; Chen S; Liu Q; Zhang B; He X; Wang Y; Li H; Li Y; Zhang T; Lu C; Yan H; Zhang M; Li Q; Cao B; Bai Z; Wang J; Zhang Z; Zhu S; Zheng J; Ou X; Ma H; Jia J; You H; Wang S; Huang J
    EBioMedicine; 2015 May; 2(5):438-46. PubMed ID: 26137588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibody recognition of an N-terminal epitope of hnRNP L marks the risk for developing HBV-related hepatocellular carcinoma.
    Yau WY; Shih HC; Tsai MH; Sheu JC; Chen CH; Chow LP
    J Proteomics; 2013 Dec; 94():346-58. PubMed ID: 24125732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration of IgG and IgA autoantibodies for early diagnosis of hepatocellular carcinoma.
    Yang T; Lin X; Zhang L; Yu L; Wu Q; Zhang S; Qiu F; Huang Y
    Clin Chim Acta; 2021 Dec; 523():423-429. PubMed ID: 34728178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and Validation of Serum Autoantibodies Against Tumor-Associated Antigens as Biomarkers in Gastric Adenocarcinoma Based on the Focused Protein Arrays.
    Yang Q; Qin J; Sun G; Qiu C; Jiang D; Ye H; Wang X; Dai L; Zhu J; Wang P; Zhang J
    Clin Transl Gastroenterol; 2020 Dec; 12(1):e00284. PubMed ID: 33346593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.